Validation of a miRNA Panel to Optimize Treatment Response in Patients With Metastatic Pancreatic Cancer (mirPANC 2)
RecruitingOBSERVATIONAL
Enrollment
60
Participants
Timeline
Start Date
January 21, 2025
Primary Completion Date
October 31, 2027
Study Completion Date
December 31, 2027
Conditions
Pancreatic CancerMetastasisEpigenetic
Trial Locations (1)
Unknown
RECRUITING
A Beneficência Portuguesa de São Paulo, São Paulo
All Listed Sponsors
lead
Benedito Mauro Rossi
OTHER
NCT06945978 - Validation of a miRNA Panel to Optimize Treatment Response in Patients With Metastatic Pancreatic Cancer (mirPANC 2) | Biotech Hunter | Biotech Hunter